Asthma Study Now Enrolling in Dallas to Evaluate New Inhaler Treatment
Txylo.com/10314522
Trending...
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 132
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More - 114
- Texas: Governor Abbott Attends Grand Opening Of Buc-ee's In San Marcos
Local Participants Needed – Receive Study-Related Care and Treatment at No Cost
DALLAS - Txylo -- Lonestar Clinical Research is now enrolling participants for a clinical study in Dallas evaluating a new inhaler treatment for asthma. The study offers no-cost care, requires no insurance, and provides a chance for local residents to help shape the future of asthma treatment.
Asthma is a major health concern in the Dallas area, affecting nearly 1 in 10 residents. Each year, more than 8,000 emergency room visits in the Dallas region are linked to asthma-related complications.
"If you live with asthma, your experience matters," said Dr. Ebuh- principal investigator at Lonestar Clinical Research. "This study offers an opportunity to not only access potential new treatment options at no cost but also contribute to important research that could benefit others living with asthma in our community."
More on Txylo.com
Why This Study Matters:
To learn more about the study or find out if you qualify, visit https://joinlonestarasthmastudy.com/
or call Lonestar Clinical Research at 214-177-7722
About Lonestar Clinical Research
We strive to provide every volunteer with the best level of care. Our friendly, experienced, and knowledgeable staff members make sure that each patient is informed, comfortable, and satisfied with their participation in clinical research.
Asthma is a major health concern in the Dallas area, affecting nearly 1 in 10 residents. Each year, more than 8,000 emergency room visits in the Dallas region are linked to asthma-related complications.
"If you live with asthma, your experience matters," said Dr. Ebuh- principal investigator at Lonestar Clinical Research. "This study offers an opportunity to not only access potential new treatment options at no cost but also contribute to important research that could benefit others living with asthma in our community."
More on Txylo.com
- United Staff Source Announces Transition to United OPS
- Scientific Figure Releases Free Layout Template Libraries for Graphical Abstracts and Research Posters
- Johanna Sparrow® Announces the Release of Mastering Healthy Attachments: The Attachment Drama Healing Method™ Training Program
- SoulTalk Inc. Launches Non-Chatbot AI Journaling App Built for Self-Growth
- Permian Museum announces the addition of an Ancient Alien Artifacts photo gallery
Why This Study Matters:
- Asthma impacts thousands across Dallas
- A new inhaler is being evaluated for effectiveness and safety
- Your participation could help improve care for yourself and others
- No cost. No insurance needed. Compensation available.
To learn more about the study or find out if you qualify, visit https://joinlonestarasthmastudy.com/
or call Lonestar Clinical Research at 214-177-7722
About Lonestar Clinical Research
We strive to provide every volunteer with the best level of care. Our friendly, experienced, and knowledgeable staff members make sure that each patient is informed, comfortable, and satisfied with their participation in clinical research.
Source: Lonestar Clinical Research
Filed Under: Health
0 Comments
Latest on Txylo.com
- Weekly News Wrap-Up: Business, Law & More from the Price of Business Network- Aug 14th, 2026
- Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
- Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
- Texas: Governor Abbott Announces Amazon, Lancium And Cipher Digital Commit To Comply With His Data Center Standards
- 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
- Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
- Hollywood In Pixels Announces Honorees for The 9th Silver PIXel Awards
- New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
- GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
- LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards
- Website Maintenance Services in Texas Help Businesses Stay Online
- Hendricks Property Management Joins the National Federation of Independent Business
- Bronze Stevie Award Recognizes Satyadhar Joshi for AI Research and Public Policy Engagement
- HVAC Pflugerville Opens as a Trusted Choice for Central Texas Home Comfort
- synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
- Texas: Governor Abbott Announces Galaxy, Compass Datacenters And Montera Infrastructure Commit To Comply With His Data Center Standards
- Leading PDR Training Courses in Canada: Learn Paintless Dent Repair with PDR Academy & Tint Academy
- Houston's Olivo Remodeling Earns Third Consecutive BBB Award for Excellence
- Move in this Fall! New Released Quick Move-In Townhomes at Heritage at South Brunswick with Limited-Time Incentives
- A New World Record Is Coming: The Tallest Christmas Tree Ever Built, for America's 250th